Involvement of Src kinases and PLCγ2 in clot retraction

Citations of this article
Mendeley users who have this article in their library.


The integrin α IIb β 3 plays a critical role in mediating clot retraction by platelets which is important in vivo in consolidating thrombus formation. Actin-myosin interaction is essential for clot retraction. In the present study, we demonstrate that the structurally distinct Src kinase inhibitors, PP2 and PD173952, significantly reduced the rate of clot retraction, but did not prevent it reaching completion. This effect was accompanied by abolition of α IIb β 3 -dependent protein tyrosine phosphorylation, including PLCγ2. A role for PLCγ2 in mediating clot retraction was demonstrated using PLCγ2-deficient murine platelets. Furthermore, platelet adhesion to fibrinogen leads to MLC phosphorylation through a pathway that is inhibited by PP2 and by the PLC inhibitor, U73122. These results demonstrate a partial role for Src kinase-dependent activation of PLCγ2 and MLC phosphorylation in mediating clot retraction downstream of integrin α IIb β 3 . © 2006 Elsevier Ltd. All rights reserved.




Suzuki-Inoue, K., Hughes, C. E., Inoue, O., Kaneko, M., Cuyun-Lira, O., Takafuta, T., … Ozaki, Y. (2007). Involvement of Src kinases and PLCγ2 in clot retraction. Thrombosis Research, 120(2), 251–258.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free